Literature DB >> 16901382

Treating persistent adolescent aggression.

John Peterson1, Christopher Sheldon.   

Abstract

Adolescent aggressive behavior is a frequently encountered problem for clinicians and society as a whole. Better understanding of biological, social, and familial risk factors for maladaptive aggressive behavior may lead to more effective interventions. The social information processing problems characteristic of this group interfere with treatment and outcome. Although further studies are needed, evidence for the effectiveness of psychopharmacologic treatments is increasing. There is also evidence for several effective psychotherapeutic interventions, especially for those with affective/impulsive aggression. Knowledge of risk factors, psychosocial strategies, and psychopharmacologic treatments can enhance the clinician's ability to intervene with this difficult group.

Entities:  

Year:  2006        PMID: 16901382     DOI: 10.1007/s11940-006-0032-8

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  58 in total

1.  Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies.

Authors:  Soo Hyun Rhee; Irwin D Waldman
Journal:  Psychol Bull       Date:  2002-05       Impact factor: 17.737

2.  Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression.

Authors:  C R Pfeffer; H Jiang; L J Domeshek
Journal:  J Child Adolesc Psychopharmacol       Date:  1997       Impact factor: 2.576

3.  Acute effects of baclofen, a gamma-aminobutyric acid-B agonist, on laboratory measures of aggressive and escape responses of adult male parolees with and without a history of conduct disorder.

Authors:  Don R Cherek; Scott D Lane; Cynthia J Pietras; Jennifer Sharon; Joel L Steinberg
Journal:  Psychopharmacology (Berl)       Date:  2002-09-03       Impact factor: 4.530

4.  Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine.

Authors:  R G Beran; R J Gibson
Journal:  Epilepsia       Date:  1998-03       Impact factor: 5.864

5.  Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.

Authors:  S J Donovan; J W Stewart; E V Nunes; F M Quitkin; M Parides; W Daniel; E Susser; D F Klein
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

6.  Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study.

Authors:  Cerstin Nickel; Claas Lahmann; Karin Tritt; Moritz Muehlbacher; Patrick Kaplan; Christian Kettler; Jakub Krawczyk; Thomas H Loew; Wolfhardt K Rother; Marius K Nickel
Journal:  J Affect Disord       Date:  2005-08       Impact factor: 4.839

7.  A double-blind pilot study of risperidone in the treatment of conduct disorder.

Authors:  R L Findling; N K McNamara; L A Branicky; M D Schluchter; E Lemon; J L Blumer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-04       Impact factor: 8.829

8.  Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.

Authors:  Russell E Scheffer; Robert A Kowatch; Thomas Carmody; A John Rush
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

9.  Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children.

Authors:  J K Zubieta; N E Alessi
Journal:  J Clin Psychopharmacol       Date:  1992-10       Impact factor: 3.153

10.  Risperidone in children with autism and serious behavioral problems.

Authors:  James T McCracken; James McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald Lindsay; Patricia Nash; Jill Hollway; Christopher J McDougle; David Posey; Naomi Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder Ghuman; Nilda M Gonzalez; Marco Grados; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  1 in total

1.  Pharmacologic treatment of impulsive aggression with antiepileptic drugs.

Authors:  Matthew S Stanford; Nathaniel E Anderson; Sarah L Lake; Robyn M Baldridge
Journal:  Curr Treat Options Neurol       Date:  2009-09       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.